These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prediction of 3- to 5-Month Outcomes from Signs of Acute Bilirubin Toxicity in Newborn Infants. El Houchi SZ, Iskander I, Gamaleldin R, El Shenawy A, Seoud I, Abou-Youssef H, Wennberg RP. J Pediatr; 2017 Apr; 183():51-55.e1. PubMed ID: 28131490 [Abstract] [Full Text] [Related]
3. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. J Perinatol; 2009 Feb; 29 Suppl 1():S25-45. PubMed ID: 19177057 [Abstract] [Full Text] [Related]
12. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. Bhutani VK, Johnson LH, Jeffrey Maisels M, Newman TB, Phibbs C, Stark AR, Yeargin-Allsopp M. J Perinatol; 2004 Oct; 24(10):650-62. PubMed ID: 15254556 [Abstract] [Full Text] [Related]
14. Unbound Bilirubin and Acute Bilirubin Encephalopathy in Infants Born Late Preterm and Term with Significant Hyperbilirubinemia. Amin SB, Saluja S, Kler N. J Pediatr; 2024 Mar; 266():113880. PubMed ID: 38135027 [Abstract] [Full Text] [Related]